Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma.

Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma. Abstract Text:

    susan e spillerSusan E Spiller,ali c ravanpayAli C Ravanpay,andrew w hahnAndrew W Hahn,james m olsonJames M Olson,

    PURPOSE: Suberoylanilide hydroxamic acid (SAHA) has been studied in adult solid and hematologic malignancies. However, little information has been reported on the effects of SAHA on central nervous system (CNS) tumors including medulloblastoma, the most common malignant brain tumor in children. We investigated SAHA in preclinical medulloblastoma models to determine its anti-cancer efficacy as well as its ability to affect intracranial lesions when administered systemically. EXPERIMENTAL DESIGN AND RESULTS: Tissue culture studies were performed treating primary human fibroblasts, established medulloblastoma cell lines, and primary human medulloblastoma tumors with SAHA. At 10 microM concentration, SAHA had little effect on normal fibroblasts but caused >90% apoptosis in cultured medulloblastoma cells. Primary medulloblastomas from patients were sensitive to SAHA compared to vehicle alone in ex vivo studies. In athymic mice with medulloblastoma xenograft tumors, oral SAHA resulted in apoptosis of tumor tissue and significantly slowed tumor growth. In the ND2:Smo transgenic mouse medulloblastoma model, SAHA treatment caused significant apoptosis in these cerebellar tumors. CONCLUSIONS: SAHA effectively induces cell death in established medulloblastoma cell lines, human patient primary tumor cultures, medulloblastoma xenografts and intracranial spontaneous medulloblastomas. Fibroblasts in culture and mice treated with SAHA did not reveal prohibitive toxicity profiles. These findings support the advancement of SAHA to pediatric clinical trials.

    Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma. Publishing Authors By Initials

    se spillerSE Spiller,ac ravanpayAC Ravanpay,aw hahnAW Hahn,jm olsonJM Olson,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Journal of neuro-oncology

    VOLUME: 79

    Page Numbers: 259-70

    Journal Abbreviation:

    ISSN: 0167-594X

    DAY: 28

    MONTH: 04

    YEAR: 2006

    Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8309335

    Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma.

    AFFILIATION: Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Seattle, WA 98109, USA.

    Country: Netherlands

    Netherlands Research PublicationNetherlands Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Neurooncol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News